Інформація призначена тільки для фахівців сфери охорони здоров'я, осіб,
які мають вищу або середню спеціальну медичну освіту.

Підтвердіть, що Ви є фахівцем у сфері охорони здоров'я.

"Child`s Health" Том 12, №3, 2017

Back to issue

The content of antimicrobial proteins in children with respiratory tract inflammatory diseases

Authors: G.A. Lezhenko(1), A.Ye. Abaturov(2), E.Ye. Pashkova(1), K.V. Gladun(1)
(1) — Zaporizhia State Medical University, Zaporizhzhia, Ukraine
(2) — State Institution “Dnipropetrovsk Medical Academy”, Dnipro, Ukraine

Categories: Pediatrics/Neonatology

Sections: Clinical researches

print version


У роботі проведено дослідження вмісту протимікробних пептидів у дітей із різною патологією респіраторного тракту. Установлено, що для дітей, які часто хворіють, характерні зміни показників мукозального захисту, низький вміст α-дефензинів 1–3 у секреті ротоглотки, що свідчить про напруження механізмів місцевого захисту. Установлена гіперпродукція α-дефензинів 1–3 у дітей, хворих на рецидивуючий бронхіт, на тлі порушеної рівноваги між про- і протизапальними цитокінами може бути однією з причин виникнення рецидивуючих форм перебігу інфекційного процесу респіраторного тракту.

В работе проведено исследование содержания противомикробных пептидов у детей с различной патологией респираторного тракта. Установлено, что для часто болеющих детей характерны изменения показателей мукозальной защиты, низкое содержание α-дефензинов 1–3 в ротоглоточном секрете, что свидетельствует о напряжении механизмов местной защиты. Установленная гиперпродукция α-дефензинов 1–3 у детей, больных рецидивирующим бронхитом, на фоне нарушенного равновесия между про- и противовоспалительными цитокинами может быть одной из причин возникновения рецидивирующих форм течения инфекционного процесса респираторного тракта.

The paper has investigated the content of antimicrobial peptides in children with different respiratory tract pathologies. It was found that sickly children were characterized by the changes in mucosal protection, low content of α-defensins 1–3 in oropharyngeal secretions. The revealed changes indicated the stress of the local defense mechanisms. The investigation has detected that overproduction of α-defensins 1–3 in children with recurrent bronchitis against the background of the disturbed balance between pro- and anti-inflammatory cytokines could be one of the causes of recurrent forms of the course of respiratory tract infection.


діти, які часто хворіють; рецидивуючий бронхіт; протимікробні пептиди

часто болеющие дети; рецидивирующий бронхит; противомикробные пептиды

sickly children; recurrent bronchitis; antimicrobial peptides


The leading role in protection of an organism at relationship between bacterium and the owner belongs to polymorphonuclear leukocytes that is caused by products them highly reactive metabolites of molecular oxygen, and also secretion of the proteins posses-sing antimicrobic action [1]. Inflammatory diseases of the respiratory tract are often associated with impaired synthesis of antimicrobial peptides, one of whose representatives are defensins [2]. Effect of antimicrobic peptides leads, mainly, to disturbance of structure and function of a cytoplasmic membrane of microorganisms due to change of transmembrane permeability.This, in turn, causes the progredient demineralization of the cell and leads to the death of the microorganism [3, 4]. In the process of development of the immune system, defensins were given a special immunoregulatory role. On the one hand, defensins have antiinflammatory pro-perties due to the induction of interleukin-10 secretion. On the other hand, defensins direct neutrophils, B-cells and macrophages to the inflammatory focus, leading to the release of inflammatory mediators, such as interleukin-8, -6, -10, interferon-γ and leukotrienes B4 [5, 6]. Thus, defensins act not only as endogenous antibio-tics, they also play an important role in the activation of processes of inflammation, repair and regulation of the adaptive immune response [4, 7]. The violation of the expression of defensins is accompanied by an increased risk of infectious, inflammatory, allergic and autoimmune diseases [7].
Another antimicrobial peptide is LF, which is an iron-binding glycoprotein that acts as a tissue protector against the damaging effects of hydroxyl radicals. It mediates the surface tension reactions on the cell membranes and the repulsive forces between them. The biological role of this effect lies in the retention of neutrophils in the inflammatory focus. According to a number of researchers, LF is a highly sensitive marker of any inflammatory process [8]. The propensity of patients with viral diseases to subsequent bacterial complications is consistent with the fact that individuals with congenital or acquired LF deficiency are susceptible to age-related infection [9], and testify to the biological role of this peptide in protecting the body [10].
All listed above, as well as the absence of such reports in the literature, served as a prerequisite for the present study, whose goal was to study the concentrations of these antimicrobial peptides in the oropharyngeal secretion and plasma in children with inflammatory diseases of the respiratory tract.

Materials and methods

The study group included 111 children aged 4 to 17 years from orphanages. An obligatory criterion for including children in the study was the presence of a state of somatic health and clinical well-being at the time of the survey. In addition, we conducted a comprehensive survey of 68 children with recurrent bronchitis, in the period of acute inflammation subsided in age from 5 to 16 years. The control group consisted of 30 healthy children, representative by age and sex.
Evaluation of the content of antimicrobial proteins of LF (Human Lactoferrin), α-defensins 1–3 (Human HNP1–3) in the oropharyngeal secretion in children was carried out using the elisa kit of the test systems Hycult®biotech, NTV, BioChimMac, and SIgA in the oropharyngeal secretion — using a set of reagents IgA secretory — ELISA-BEST; Russia, Novosibirsk, ZAO “Vector-Best”. The content of antimicrobial peptides — α-defensins 1–3 (Human Neutrophil Peptides 1–3, HNP1–3) in blood plasma was studied by immunoassay using the commercial kit HNP1–3 (ELISA, Bio Tech Lab-S). Determination of interleukin-6 and -10 content in blood serum was carried out using commercial sets for the enzyme immunoassay interleukin-6 and -10 (DRG, USA). 
The obtained results are processed by the variational statistics method using the Statistic for Windows 6.0 program analysis package with the function of calculating the arithmetic mean (M), the standard deviation (σ) and the mean errors (m). To assess the differences in the indicators in the compared groups, the t-test of the Student was used. Distinctions considered reliable at р < 0,05.


Analysis of anamnestic data in somatically healthy children from orphanages showed the presence of 4 to 6 episodes of acute respiratory infections throughout the year, the duration of which averaged 5.3 ± 0.4 days, while the children in the control group had no more than two acute respiratory infections a year. Chronic lesions of upper respiratory tract infections have been reported in 85 examined children (84.2 %), among which compensated chronic tonsillitis observed in 69 % of the patients (70 children), adenoid vegetation in 19 % of the patients (20 children). An adenotomy was carried out at 15 (13.5 %) children, tonsilectomies — at 5 (4.5 %) children. Ten (9.0 %) children suffered from acute sinusitis, manifestations of caries in the history were noted in half of our observations.
A characteristic feature of the group of patients with recurrent bronchitis was the prevalence of preschool and primary school age children (47 children — 69.1 %). Frequency of exacerbations of bronchitis fluctuated within 3–7 episodes a year and averaged 5.3 ± 0.3 episodes. Development of 3–4 episodes of bronchitis per year was observed in 36 (52.9 %) children, 5–6 episodes a year — in 25 (36.8 %) children, and the presence of more than 6 episodes of bronchitis per year was noted in 7 (10.3 %) of children with recurrent bronchitis. Exacerbations of bronchitis were mainly provoked by acute respiratory viral diseases. The average duration of exacerbations of bronchitis was 20.6 ± 0.9 days. The acute period of the inflammatory process in 58 (85,3 %) children was 2–3 weeks, in 7 (10.3 %) patients — 4–6 weeks, and in 3 (4.4 %) patients — more than 6 weeks.
Comorbidity of ENT organs were found in most patients with recurrent bronchitis (53 children — 77.9 %), among which 24 (35.3 %) children experienced chro-nic adenoids, 13 (19,1 %) patients were diagnosed with chronic tonsillitis, and 16 (23.5 %) patients had chronic sinusitis. Hypertrophy of the lymphatic oropharyngeal ring was found in 14 (20.6 %) patients.
According to the results of a microbiological examination of the mucous membranes of the throat and nose of frequent sick children and episodically ill children from the organized collectives, they had similar characteristics of pharyngeal and nasal biocenosis, with a slightly higher coefficient of bacterial presence in children, who often were ill, due to variety of species of normal mucosal microflora and presence of different representatives of opportunistic flora. 
It can be assumed that the children surveyed from the organized collectives had approximately the same characteristics of the state of microbial colonization of the throat and nose mucous, but some of them realized a high incidence of acute respiratory illness in the clinic, while the other part had sufficient compensation for local immunity, which is most likely due to properties and features of biofilm, the functional activity of which directly depends on the quality characteristics of normal microflora.
According to the results of present study in the period of clinical well-being in frequently ill children from pharyngeal mucosa were sowed 12 species, from the nasal mucosa — 9 species of bacteria. Thus, in the frequently ill childrendominance of growth of streptococci of the viridians group (53.3 %), Staphylococcus aureus (46.7 %) and gramnegative cocci — bacteria of the genus Neisseria (43.4 %) was registered. Slightly more rarely, in 26.6 % of cases, opportunistic streptococci were sown from mucous of throat (Strep. haemolyticus and Strep. рyogenes — 13.3 %, respectively). Incidentally was re–gistered growth of epidermal staphylococcus (5 % of observations), diphtheroids (Cor. pseudodiphtheribicum and Cor. хerosis — 5 and 3.3 % respectively) and fungi of the genus Candida (5 %). In a few cases, the presence of Pseudomonas aeruginosae (1.6 %), bacteria of the genus Enterobacter (1.6 %) and E. coli (1.6 %) were registered in the mucous membrane.
Analysis of the results of crops from mucous membranes in frequently ill children showed that in the seeding of this level the leading role was played by grampositive cocci: epidermal (56.7 %) and golden (22.2 %) staphylococci. Non-toxic corynebacteria diphtheria or diphtheria were sown in 20 % of cases (Cor. рseudodiphtheribicum and Cor. хerosis, respectively, 10 % each). The remai–ning microorganisms were less common — Strep. viridans (13.3 %), Haemophilus influenza (6.7 %) and Neisse-riae spp. (3.3 %). In rare cases, it recorded growth of Strep. haemolyticus (1.6 %) and Strep. pyogenes (1.6 %).
Frequently ill children in the overwhelming majori-ty of cases (75 %) have been registered the sowing of at least three or more species of bacteria, among which a high proportion fell on Staph. aureus and other opportunistic bacteria with high growth titers (> 104 cfu/ml). The normal flora dominated the mucous membranes of both the throat and nose, but it should be noted that a part of the examined children (20 % of cases) registered high growth titers of normal microflora of throat (Neisseriae spp., up to 107 and Strep. viridans up to 1015) and nose (Cor. xerosis and Strep. viridans up to 107), which, in combination with the registration of a high growth titer of opportunistic pathogenic flora, allows to establish the presence of dysbiosis in 83.3 % of cases. This necessitated the study of the state of mucosal immunity.
According to the results of bacteriological exa-mination of smears from the nose, oropharynx and sputum of children with recurrent bronchitis, it was established that the dominant microflora was from Haemophilus genus, which was found in 32 (47.1 %) patients. Among the strains of the pathogen H. influenzae found in 20 (29.4 %) patients, H. haemolyticus — in 4 (5.9 %), H. parainfluenzae — in 3 (4.4 %) and H. parahaemolyticus — in 5 (7.4 %) patients. In addition, 14 (20.6 %) children had S. pneumoniae as an etiological factor, 8 (11.8 %) had Klebsiella pneumonia, and 5 (7.4 %) had Enterococcus faecalis. Other pathogens were much less common, i.e. S. pyogenes was detected in 2 (2.9 %) children, Klebsiella pneumonia — in 3 (4.4 %) and Proteus mirabilis — in 1 (1.5 %) patients. In 3 (4.4 %) patients, the presence of a fungal-bacterial association was established. Thus, for children with recurrent bronchitis, the primary colonization of the respiratory tract with a haemophilic rod was characteristic, which confirmed the literature data on the significant role of this microorganism in the development and support of inflammation in respiratory tract infections [11].
The results of an immunological study of frequently and episodically ill children in the period of clinical well-being are presented in table 1. According to our data, a significantly low content of antimicrobial protein α-defensin HNP1–3 and SIgA in the period of clinical health in the oropharyngeal secretion was registered in frequently ill children in comparison with the group of episodically sick children (p < 0.05). In 22 frequently ill children, concentrations of secretory immunoglobulin A were 5–10 times lower (SIgA ≤ 46 mg/L, 22 children) of healthy people 370–670 mg/l. The content of lactoferrin in the oropharyngeal secretion in frequently ill child-
ren was not significantly different from the episodically sick children.
The results of our evaluation of the content of antimicrobial proteins and secretory immunoglobulin A indicate a decrease in the level of protective immunity of mucous membranes and a strain of local defense mechanisms in children with frequent diseases, which corres-ponded to the expressiveness of the dysbiotic manifestations and was confirmed by the results of the conducted correlation analysis.
The next stage of the work was to study tTabhe content of α-defensins 1–3 in the blood plasma of children with recurrent bronchitis (table 2).
According to the results of the study, the content of this antimicrobial peptide in the blood plasma of the children of the control group was 3583.3 ± 735.4 pg/ml, while in the group of children with recurrent bronchitis the α-defensin level was 1–3 times higher than the results obtained almost twice and was 6576.7 ± 602.8 pg/ml, p < 0.01.
In the study of the serum cytokine profile, it was found that in children with recurrent bronchitis compared with the control group, the content of proinflammatory interleukin-6-cytokine, which regulates the inflammatory process and provides mobilization of the inflammatory response, as well as an antigen-specific immune response, had only a tendency to increase (10.1 ± 2.0 pg/ml vs 9.1 ± 1.1 pg/ml in the control group, p > 0.05). Against this background, we observed an increase of more than 3 times the level of antiinflammatory interleukin-10, which is a product of type 2 helper cells, responsible for the formation of a humoral antigenspecific immune answer — 4.42 ± 1.0 pg/ml vs 1.41 ± 0.59 pg/ml, respectively (p < 0.05). As is known, excess interleukin-10 leads to a decrease in antiinfective protection and may contribute to chronic inflammation in the respiratory tract [12]. Thus, there was an imbalance between pro- and antiinflammatory cytokines in children with recurrent bronchitis.


Among the many molecular effectors of the non-specific defense system of the respiratory tract, the metal-binding protein lactoferrin occupies a special place and is evolutionarily the youngest member of the transferrin family, cationically active iron-binding glycoproteins [13, 14]. Lactoferrin is a natural antibacterial, antifungal and antiviral protein, has antioxidant and immunomodulating properties. Antibacterial properties of the protein are due to the ability of lactoferrin to bind iron and thereby deprive the bacterial microflora necessary for its growth and vital activity microelement [13]. The bactericidal properties of LF are also due to the presence of specific lactoferrin receptors on the cell surface of microorganisms, and the bacteriostatic effect is achieved due to intracellular changes in bacteria, without violating membrane permeability [15]. The bacteriostatic effect of apo-LF against of Strep. mutans, S. salivarius, S. mutior, S. pneumonial, Vibro cholerae 5698, Pseudomonas aeruginosa has been proved [16]. LF also causes changes in the permeability of the outer membrane of some gramnegative bacteria [17], and the LF of cow’s milk shows bacteriostatic activity against of E. coli [18]. Lactoferrin has antiviral activity against a broad spectrum of human and animal viruses with DNA and RNA genomes [19]. At this point shown the effect of LF against herpes simplex virus 1 and 2, cytomegalovirus, HIV, hepatitis C virus, hantavirus, rotavirus, poliovirus first type, adenoviruses, respiratory syncytial virus [20–22], murine leukemia virus Freund [23]. The most studied mechanism of the antiviral activity of lactoferrin is the prevention of the entry of viral particles into target cells [24]. In addition to interaction with cellular receptors, lactoferrin directly binds to viral particles and prevents their penetration into cells, which is confirmed by the antiviral action of the LF protein against rotaviruses, for which the cellular receptors are hydrocarbon residues differing in composition from glycosaminoglycans.
Defensins are cationic peptides of the immune system that are active against bacteria, fungi and many enveloped and non-enveloped viruses [25]. Immune cells use defensins to kill bacteria, absorbed in phagocytosis. Typically, defensins attach to the cell membrane of the microbe and deepen into it, forming porous-like discontinuities [26, 27]. Among human antimicrobial proteins, α-defensins 1–3 are unique, neutrophils contain up to 99 % of all defensins, and therefore only neutrophils are practically the only source of HNP1–3 in blood plasma and other body fluids [28, 29]. According to the published data, the increase of α-defensins is registered against a background of significant activation of acute or chronic inflammatory process, reaching a maximum at sepsis. Furthermore, HNP1–3 have a bactericidal effect, chemotactic, immunomodulatory and cytotoxic acti-vity. It has been proved that HNP1–3 have antiviral effect, contributing to anti-HIV-1 activity of CD8 antiviral factor [30].
Taking into account the above data on the known mechanisms of action of antimicrobial proteins of lactoferrin and defensins and taking into account the results of the study, it can be stated that the frequently ill children have changes in the mucosal protection indexes, and a significantly low content of α-defensins 1–3 in the oropharyngeal secret in comparison with episodically ill children allows to assert about the lack in the FIC in the period of clinical well-being of acute or exacerbation of a chronic infectious process and the absence of activation or enhancement neutrophilic inflammatory process in the bodies of the examined children.
At the same time, at the present stage it is proved that high levels of α-defensins induce the release of interleukin-8 and neutrophil-activating protein 78 from respiratory epithelial cells, which leads to additional migration of polymorphonuclear leukocytes to the inflammatory focus [3, 31]. Excessive accumulation of neutrophils in the lung parenihime and capillaries, in turn, contributes to a local “protease explosion” to damage the components of surfactant, the basement membrane of alveoli and of the endothelial cells. In addition, α-defensins 1–3 in high concentrations increase the permeability of the microcirculatory network both directly and by stimulation of mast cell degranulation [31, 32]. That is, under such conditions, the compensatory-adaptation reaction, aimed at overcoming the contamination of the pathogen, takes on the character of a pathological and acts as an additional factor in the destruction of the respiratory system. It should be noted that high concentrations of defensins inhibit the phagocytic activity of neutrophils [33]. Thus, in children with recurrent bronchitis, there is an increased production of α-defensins 1–3, in all probability, induced by bacterial agents. However, this superproduction of α-defensins can cause inhibition of phagocytosis by polymorphonuclear leukocytes, which leads to the appearance of recurrent forms of the infection process of the respiratory tract.


1. For frequently ill children in the period of clinical well-being is characteristically a decrease in the level of protective immunity of mucous membranes and strain of local defense mechanisms, which is manifested by a low content of antimicrobial protein α-defensin HNP1–3 and SIgA in the oropharyngeal secretion.
2. The development of recurrent bronchitis in children is accompanied by an increase in the level of α-defensins 1–3 in blood plasma.
3. In children with recurrent bronchitis, there is an imbalance between pro and anti-inflammatory cytokines, manifested by an increase in interleukin-10 serum levels against a background of insufficient synthesis of interleukin-6.
Conflicts of interests. Authors declare the absence of any conflicts of interests that might be construed to influence the results or interpretation of their manuscript.


1. Surkova ЕА, Bulgakova ТV, Sologub ТS, et al., compilers. Mieloperoksidaza i laktoferrin u bolnyih mukovistsidozom [Myeloperoxidase and lactoferrin in patients with cystic fibrosis]. Meditsinskaya immunologiya. 2004;1–2:67-74. (in Russian).
2. Lillard JW Jr, Boyaka PN, Chertov O, et al., compilers. Mecha-
nisms for induction of acquired host immunity by neutrophil peptide defensins. Proc Natl Acad Sci USA. 1999;96:651-656. doi: 10.1073/pnas.96.2.651.
3. Van Wetering S, Mannesse-Lazeroms SPG, Van Sterkenburg MAJA, et al., compilers. Neutrophil defensins stimulate the release of cytokines by airway epithelial cells: modulation by dexamethasone. Inflamm Res. 2002;51:8-15. doi: 10.1007/PL00000282.
4. Yount NY, Yeaman MR, compilers. Immunoconsiluum: Perspectives in Antimicrobial Peptide Mechanisms of Action and Resistance. Protein and Peptide. Letters. 2005;49-67. doi: 10.2174/0929866053405959.
5. Rinker SD, Trombley MP, Gu X, et al., compilers. Deletion of mtr C in Haemophilus ducreyi increases sensitivity to human antimicrobial peptides and activates the CpxRA regulon. Infection and immunity. 2011; 79(6):2324-2334. doi: 10.1128/IAI.01316-10.
6. Zhang L, Yu W, He T, et al., compilers. Contribution of human α-defensin 1, 2, and 3 to the antiiHIV-1 activity of CD8 antiviral factor. Science. 2002;298:995-1000. doi: 10.1126/science.1076185.
7. Abaturov АЕ, Herasimenko ON, Vysochina IL, et al., compi-lers. Defenzinyi i defenzinzavisimyie zabolevaniya [Defensins and defensindepending diseases] [bliography]. Odesa: ВМВ; 2011. 265 p. (in Russian).
8. Shramko SV, Arhipova SV, Bazhenova LG, et al., compilers. Diagnosticheskoe znachenie nekotoryih ostrofaznyih belkov pri gnoyno-vospalitelnyih zabolevaniyah pridatkov matki [Diagnostic value of some acute-phase proteins in purulent-inflammatory diseases of the uterine appendages]. Byulleten Sibirskoy meditsinyi. 2006;3:112-116. (in Russian).
9. Baynes RD, Bezwoda WR, Khan O, Mansoor N, compilers. Relationship of plasma lactoferrin content to neutrophil regeneration and bone marrow infusion. Scand J Haematol. 1986;36:79-84. doi: 10.1111/j.1600-0609.1986.tb02654.x.
10. Birgens HS, compiler. The biological significance of Lactoferrin in haematology. Scand J Haematol. 1984;33:225-230. doi: 10.1111/j.1600-0609.1984.tb02220.x.
11. Boronina LG, compiler. Mikrobiologicheskie aspektyi infektsiy, vyizvannyih Haemophilus influenzae, u detey [Microbiological aspects of infections caused by Haemophilus influenzae in children] [bibliography]. St. Petersburg; 2007. 38 p. (in Russian).
12. Bedareva TU, Poponnikova TV, Varhammeva TN, compilers. Izmeneniya tsitokinovogo statusa i urovnya antimikrobnyih peptidov pri kleschevyih neyroinfektsiyah u detey [Changes of cytokine status and the level of antimicrobial peptides in tick neuroinfections in children]. Sibirskiy meditsinskiy zhurnal. 2008;7:22-25. (in Russian).
13. Farnaud S, Evans RW, compilers. Lactoferrin — a multifunctional protein with antimicrobial properties. Mol Immunol. 2003;40(7):395-405. doi: http://doi.org/10.1016/S0161-5890(03)00152-4.
14. Naidu AS, compiler. Lactoferrin: natural, multifunctional, antimicrobial [bibliography]. CRC Press; 2000. 184 p.
15. Anderson B, Baker H, Norris G, Rice D, et al., compilers. Structure of human lactoferrin: crystallographic structure analysis and refinement at 2.8 А resolution. J Mol Biol. 1989;209:711-734. doi: https://doi.org/10.1016/0022-2836(89)90602-5.
16. Kokryakov VR, Pygarevskiy VE, Aleshyna GM, Shamova OV, compilers. Sinergicheskoe antimikrobnoe deystvie kationnyih belkov pri fagotsitoze [Synergistic antimicrobial action of cationic proteins in phagocytosis]. Sbornik nauchnyh trudov pod redakciey Mayanskogo AN. Gorkiy; 1989. 98-103. (in Russian).
17. Ellison RT, Giehl TJ, La Force F, compilers. Damage of the oute membrane of electric gramnegative bacteria by lactoferrin and transferrin. Infect and Immun. 1988;56:2774-2781.
18. Rainard P, compiler. Bacteriostatic activity of bovine milk lactoferrin against mastitic bacteria. Vet Microbiol. 1986;11:387-392. doi: https://doi.org/10.1016/0378-1135(86)90068-4.
19. Van der Strate BW, Beljaars L, Molema G, et al., compilers. Antiviral activities of lactoferrin. Antiviral Res. 2001;52(3):225-239. doi: http://doi.org/10.1016/S0166-3542(01)00195-4.
20. Fujihara T, Hayashi K, compilers. Lactoferrin inhibits herpes simplex virus type-1 (HSV-1) infection to mouse cornea. Arch Virol. 1995;140:1469-1472. doi: 10.1007/BF01322673.
21. Harmsen MC, Swart PJ, De Bethune MP, et al., compilers. Antiviral effects of plasma and milk proteins: lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro. J Infect Dis. 1995;172:280-288. doi: https://doi.org/10.1093/infdis/172.2.380.
22. Puddu P, Borghi P, Gessani S, et al., compilers. Antiviral effect of bovine lactoferrin saturated with metal ions on early steps of human immunodeficiency virus type 1 infection. Int J Biochem Cell Biol. 1998;30(9):1055-1062. doi: http://doi.org/10.1016/S1357-2725(98)00066-1.
23. Sojar HT, Hamada N, Genco RJ, compilers. Structures involved in the interaction of Porphyromonas gingivalis fimbriae and human lactoferrin. FEBS Lett. 1998;422:205-208.
24. Nozaki A, Ikeda M, Naganuma A, et al., compilers. Identification of a lactoferrin-derived peptide possessing binding activity to hepa-titis C virus E2 envelope protein. J Biol Chem. 2003;278(12):10162-10173. doi: 10.1016/S0014-5793(98)00002-7.
25. Lehrer RI, Ganz T, compilers. Endogenous vertebrate antibiotics. Defensins, protegrins and other cysteine-rich antimicrobial peptides. Ann NY Acad Sci. 1996;797:228-239. doi: 10.1111/j.1749-6632.1996.tb52963.x.
26. Giansanti F, Rossi P, Massucci MT, et al., compilers. Antiviral activity of ovotransferrin discloses an evolutionary strategy for the defensive activities of lactoferrin. Biochem Cell Biol. 2002;80(1):125-130. doi:10.1139/o01-208.
27. Beiter K, Wartha F, Hurwitz R, et al., compilers. The Capsule Sensitizes Streptococcus pneumoniae to Defensins Human Neutrophil Proteins 1 to 3. Infect Immun. 2008;76(8):3710-3716. doi: 10.1128/IAI.01748-07.
28. Doss M, White MR, Tecle T, Hartshorn KL, compilers. Human defensins and LL-37 in mucosal immunity. J Leukoc Biol. 2010;87:79-92. doi: 10.1189/jlb.0609382.
29. Dugan AS, Maginnis MS, Jordan JA, et al., compilers. Human alpha-Defensins Inhibit BK Virus Infection by Aggregating Virions and Blocking Binding to Host Cells. J Biol Chem. 2008;283:31125-31132. doi: 10.1074/jbc.M805902200.
30. Trabattoni D, Caputo SL, Maffeis G, et al., compilers. Human alpha defensin in HIV-exposed but uninfected individuals. J Acquir Immune Defic Syndr. 2004;35:455-463. doi: 10.1097/00126334-200404150-00003.
31. Budyhina AS, Pinegin BV, compilers. Defenzinyi — multifunktsionalnyie kationnyie peptidyi cheloveka [Defensins are multifunctional human cationic peptides]. Immunopatologiya, allergologiya, infektologiya. 2008;2:31-40. (in Russian).
32. Kokryakov VN, et al., compilers. Kationnyie protivomikrobnyie peptidyi kak molekulyarnyie faktoryi immuniteta [Cationic antimicrobial peptides as molecular immunity factors]. Zhurnal mikrobio-logii, epidemiologii i immunobiologii. 2006;2:98-105. (in Russian).
33.Voglis S, Quinn K, Tullis E, et al., compilers. Human neutrophil peptides and phagocytic deficiency in bronchiectatic lungs. Am J Respir Crit Care Med. 2009;180.2:159-166. doi: 10.1164/rccm.200808-1250OC.

Back to issue